Cidara Therapeutics (CDTX) Reports Q3 Loss, Tops Revenue Estimates

Cidara Therapeutics (CDTX) delivered earnings and revenue surprises of 0.00% and 95.74%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the…